Amiodarone 150 mg Injection bulk supplier for pharma manufacturers

Amiodarone 150 Mg Injection 150 mg/3 mL and 500 mg/10 mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection

Available Strengths: 150 mg/3 mL and 500 mg/10 mL

Reference Brands: Cordarone, Pacerone(US)

Amiodarone is a key antiarrhythmic drug available in 100–400 mg tablets and 50 mg/mL IV vials. Used for serious ventricular arrhythmias, brands include Cordarone and Amiodarone Hameln. Commonly supplied to hospitals and ICUs, it is a staple in pharma B2B cardiac care procurement and institutional sourcing platforms.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Amiodarone is a broad-spectrum antiarrhythmic medication used for the treatment and prevention of life-threatening ventricular arrhythmias and atrial fibrillation. It is available in both oral (100 mg, 200 mg, 400 mg tablets) and IV (50 mg/mL) forms, typically supplied in 3 mL and 10 mL vials. Amiodarone works by prolonging the cardiac action potential and refractory period. Brands like Cordarone and Pacerone are widely used in the US, while the EU features Cordarone, Amiodarone Hameln, and Accord. Amiodarone is a high-priority cardiac care drug sourced through pharma B2B supply chains by hospitals, clinics, and institutional buyers.

Amiodarone 150 Mg Injection — third party manufacturing & bulk supply

Amiodarone 150 Mg Injection 150 mg/3 mL and 500 mg/10 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Amiodarone 150 Mg Injection is supplied as Intravenous (IV) Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Amiodarone 150 Mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Amiodarone 150 Mg Injection →

Back to Listing

Frequently Asked Questions

Amiodarone hydrochloride is used to treat and prevent serious and life-threatening cardiac arrhythmias, including ventricular tachycardia and ventricular fibrillation. It is also prescribed for certain supraventricular arrhythmias when other treatments are ineffective or contraindicated.

Amiodarone hydrochloride is a synthetic benzofuran derivative formulated as a hydrochloride salt. It works by prolonging the cardiac action potential and refractory period, helping to stabilize abnormal heart rhythms.

Amiodarone hydrochloride is sold under trade names such as Cordarone, Cordarone X, and Pacerone in different regions.

Branded versions such as Cordarone are manufactured by companies like Sanofi, while generic amiodarone hydrochloride is produced by multiple pharmaceutical manufacturers worldwide.

The complete generic name is amiodarone hydrochloride.

Cordarone, Cordarone X, and Pacerone are well-known brand names of amiodarone hydrochloride.

Amiodarone hydrochloride is manufactured in several countries including the USA, India, and European nations by GMP-compliant pharmaceutical manufacturers approved by regulatory authorities.